Stempoint Capital »

Helix Acquisition Corp Ii Cl A shares owned by Stempoint Capital

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A (HLXB) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.0M 200k 10.22
2024-03-31 $2.1M 200k 10.40

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Merus N V (MRUS)
Arcellx Common Stock (ACLX)
Amicus Therapeutics (FOLD)
Immunocore Hldgs Ads (IMCR)
Applied Therapeutics (APLT)
Merck & Co (MRK)
GSK Sponsored Adr (GSK)
Autolus Therapeutics Spon Ads (AUTL)
Cabaletta Bio (CABA)
Kalvista Pharmaceuticals (KALV)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
Adage Capital Partners GP
Citadel Advisors
T. Rowe Price Associates
Millennium Management
OZ Management
Farallon Capital Management
Dr. Jeffrey R. Jay, M.D.
Silverarc Capital Management
Perceptive Advisors
Commodore Capital
Soros Fund Management
ADAR1 Capital Management
T. Rowe Price Investment Management

View all funds holding Helix Acquisition Corp Ii Cl A